GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Retained Earnings

Covalon Technologies (TSXV:COV) Retained Earnings : C$-36.31 Mil (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Covalon Technologies's retained earnings for the quarter that ended in Jun. 2024 was C$-36.31 Mil.

Covalon Technologies's quarterly retained earnings increased from Dec. 2023 (C$-39.22 Mil) to Mar. 2024 (C$-37.76 Mil) and increased from Mar. 2024 (C$-37.76 Mil) to Jun. 2024 (C$-36.31 Mil).

Covalon Technologies's annual retained earnings declined from Sep. 2021 (C$-24.24 Mil) to Sep. 2022 (C$-33.91 Mil) and declined from Sep. 2022 (C$-33.91 Mil) to Sep. 2023 (C$-38.37 Mil).


Covalon Technologies Retained Earnings Historical Data

The historical data trend for Covalon Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Retained Earnings Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.77 -47.72 -24.24 -33.91 -38.37

Covalon Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.49 -38.37 -39.22 -37.76 -36.31

Covalon Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Covalon Technologies  (TSXV:COV) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Covalon Technologies Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Amir Boloor Director
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies Headlines

No Headlines